Han C. Effects of Yi Shen Juan Bi (YJB) pill on Experimental Rheumatoid Arthritis. Chinese Journal of Natural Medicines 8, 57-61

dc.contributor.authorPerera, P. K.
dc.contributor.authorPeng, C.
dc.contributor.authorXue, L.
dc.contributor.authorLi, Y.
dc.contributor.authorFang, W.
dc.date.accessioned2012-07-10T08:34:03Z
dc.date.available2012-07-10T08:34:03Z
dc.date.issued2010
dc.description.abstractAim To investigate the effects of Yishen Juanbi (YJB) on rheumatoid arthritis (RA), using Freund's complete induced adjuvant arthritis (AA) in rat model. Methods AA was evaluated by measuring paw swelling and rats' secondary organ indexes. The level of serum tumor necrosis factor alpha (TNF-a), interleukin-1ß (IL-1ß) and interleukin-6 (IL-6) in rats were further measured by enzyme linked immunosorbent assay (ELISA). Also, total nitric oxide synthase (tNOS) and inducible nitric oxide synthase (iNOS) were assayed in serum using nitric oxide synthase kits by spectrophotometry. Antiapoptotic Bcl-2 was examined by Western blot. Result The administration of YJB significantly inhibited the swelling of the adjuvant-non-injected footpad of AA rats while without significant effect on rats' secondary organ indexes. YJB significantly decreased the production of serum TNF-a, IL-1ß, IL-6, iNOS and over-production of Bcl-2 expression in synovium. Conclusion YJB possesses anti-rheumatic activity by modulating the main anti-inflammatory factors while down-regulating antiapoptotic Bcl-2 in AA.en_US
dc.identifier.urihttp://archive.cmb.ac.lk/handle/70130/2630
dc.language.isoenen_US
dc.titleHan C. Effects of Yi Shen Juan Bi (YJB) pill on Experimental Rheumatoid Arthritis. Chinese Journal of Natural Medicines 8, 57-61en_US
dc.typeResearch paperen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
abstracts- dr_p_k_perera _6_.pdf
Size:
212.43 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: